vs
Side-by-side financial comparison of Electromed, Inc. (ELMD) and LCNB CORP (LCNB). Click either name above to swap in a different company.
LCNB CORP is the larger business by last-quarter revenue ($23.9M vs $18.9M, roughly 1.3× Electromed, Inc.). LCNB CORP runs the higher net margin — 23.7% vs 14.6%, a 9.1% gap on every dollar of revenue. On growth, Electromed, Inc. posted the faster year-over-year revenue change (16.3% vs 5.1%). LCNB CORP produced more free cash flow last quarter ($33.4M vs $2.4M). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs 15.7%).
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.
ELMD vs LCNB — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.9M | $23.9M |
| Net Profit | $2.8M | $5.7M |
| Gross Margin | 78.4% | — |
| Operating Margin | 19.2% | 29.2% |
| Net Margin | 14.6% | 23.7% |
| Revenue YoY | 16.3% | 5.1% |
| Net Profit YoY | 40.3% | -7.6% |
| EPS (diluted) | $0.32 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.9M | $23.9M | ||
| Q3 25 | $16.9M | $23.8M | ||
| Q2 25 | $17.4M | $22.8M | ||
| Q1 25 | $15.7M | $21.5M | ||
| Q4 24 | $16.3M | $22.7M | ||
| Q3 24 | $14.7M | $21.4M | ||
| Q2 24 | $14.8M | $19.3M | ||
| Q1 24 | $13.9M | $17.8M |
| Q4 25 | $2.8M | $5.7M | ||
| Q3 25 | $2.1M | $6.9M | ||
| Q2 25 | $2.2M | $5.9M | ||
| Q1 25 | $1.9M | $4.6M | ||
| Q4 24 | $2.0M | $6.1M | ||
| Q3 24 | $1.5M | $4.5M | ||
| Q2 24 | $1.8M | $925.0K | ||
| Q1 24 | $1.5M | $1.9M |
| Q4 25 | 78.4% | — | ||
| Q3 25 | 78.1% | — | ||
| Q2 25 | 78.3% | — | ||
| Q1 25 | 78.0% | — | ||
| Q4 24 | 77.7% | — | ||
| Q3 24 | 78.3% | — | ||
| Q2 24 | 76.2% | — | ||
| Q1 24 | 74.8% | — |
| Q4 25 | 19.2% | 29.2% | ||
| Q3 25 | 15.8% | 35.6% | ||
| Q2 25 | 17.5% | 31.6% | ||
| Q1 25 | 13.6% | 25.6% | ||
| Q4 24 | 15.6% | 32.9% | ||
| Q3 24 | 13.2% | 24.9% | ||
| Q2 24 | 15.7% | 4.9% | ||
| Q1 24 | 13.3% | 12.5% |
| Q4 25 | 14.6% | 23.7% | ||
| Q3 25 | 12.6% | 29.1% | ||
| Q2 25 | 12.7% | 26.0% | ||
| Q1 25 | 12.1% | 21.4% | ||
| Q4 24 | 12.1% | 27.0% | ||
| Q3 24 | 10.0% | 21.2% | ||
| Q2 24 | 12.3% | 4.8% | ||
| Q1 24 | 10.8% | 10.7% |
| Q4 25 | $0.32 | $0.40 | ||
| Q3 25 | $0.25 | $0.49 | ||
| Q2 25 | $0.26 | $0.41 | ||
| Q1 25 | $0.21 | $0.33 | ||
| Q4 24 | $0.22 | $0.44 | ||
| Q3 24 | $0.16 | $0.31 | ||
| Q2 24 | $0.20 | $0.07 | ||
| Q1 24 | $0.17 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.8M | $21.6M |
| Total DebtLower is stronger | — | $104.4M |
| Stockholders' EquityBook value | $45.4M | $273.9M |
| Total Assets | $54.9M | $2.2B |
| Debt / EquityLower = less leverage | — | 0.38× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.8M | $21.6M | ||
| Q3 25 | $14.1M | $35.9M | ||
| Q2 25 | $15.3M | $49.8M | ||
| Q1 25 | $15.2M | $37.7M | ||
| Q4 24 | $16.2M | $35.7M | ||
| Q3 24 | $13.9M | $39.4M | ||
| Q2 24 | $16.1M | $34.9M | ||
| Q1 24 | $11.7M | $33.0M |
| Q4 25 | — | $104.4M | ||
| Q3 25 | — | $104.7M | ||
| Q2 25 | — | $105.0M | ||
| Q1 25 | — | $104.6M | ||
| Q4 24 | — | $155.2M | ||
| Q3 24 | — | $155.7M | ||
| Q2 24 | — | $162.2M | ||
| Q1 24 | — | $162.6M |
| Q4 25 | $45.4M | $273.9M | ||
| Q3 25 | $44.7M | $269.9M | ||
| Q2 25 | $43.2M | $263.5M | ||
| Q1 25 | $43.9M | $258.7M | ||
| Q4 24 | $43.6M | $253.0M | ||
| Q3 24 | $41.5M | $253.2M | ||
| Q2 24 | $44.5M | $245.2M | ||
| Q1 24 | $42.5M | $233.7M |
| Q4 25 | $54.9M | $2.2B | ||
| Q3 25 | $53.6M | $2.2B | ||
| Q2 25 | $53.8M | $2.3B | ||
| Q1 25 | $52.5M | $2.3B | ||
| Q4 24 | $52.3M | $2.3B | ||
| Q3 24 | $48.9M | $2.3B | ||
| Q2 24 | $52.2M | $2.4B | ||
| Q1 24 | $48.9M | $2.3B |
| Q4 25 | — | 0.38× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.40× | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.66× | ||
| Q1 24 | — | 0.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $34.4M |
| Free Cash FlowOCF − Capex | $2.4M | $33.4M |
| FCF MarginFCF / Revenue | 12.7% | 140.2% |
| Capex IntensityCapex / Revenue | 3.4% | 4.0% |
| Cash ConversionOCF / Net Profit | 1.10× | 6.08× |
| TTM Free Cash FlowTrailing 4 quarters | $7.9M | $54.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $34.4M | ||
| Q3 25 | $169.0K | $14.0M | ||
| Q2 25 | $3.9M | $5.5M | ||
| Q1 25 | $2.1M | $2.2M | ||
| Q4 24 | $3.2M | $93.2M | ||
| Q3 24 | $2.3M | $11.9M | ||
| Q2 24 | $4.5M | $54.9M | ||
| Q1 24 | $1.4M | $-11.9M |
| Q4 25 | $2.4M | $33.4M | ||
| Q3 25 | $-83.0K | $13.7M | ||
| Q2 25 | $3.7M | $5.2M | ||
| Q1 25 | $1.9M | $2.1M | ||
| Q4 24 | $2.9M | $89.4M | ||
| Q3 24 | $2.3M | $10.5M | ||
| Q2 24 | $4.5M | $53.8M | ||
| Q1 24 | $1.3M | $-12.8M |
| Q4 25 | 12.7% | 140.2% | ||
| Q3 25 | -0.5% | 57.4% | ||
| Q2 25 | 21.4% | 23.0% | ||
| Q1 25 | 12.2% | 10.0% | ||
| Q4 24 | 18.0% | 394.0% | ||
| Q3 24 | 15.5% | 49.0% | ||
| Q2 24 | 30.1% | 278.6% | ||
| Q1 24 | 9.1% | -71.8% |
| Q4 25 | 3.4% | 4.0% | ||
| Q3 25 | 1.5% | 1.3% | ||
| Q2 25 | 0.8% | 1.0% | ||
| Q1 25 | 1.0% | 0.3% | ||
| Q4 24 | 1.4% | 16.7% | ||
| Q3 24 | 0.3% | 6.7% | ||
| Q2 24 | 0.1% | 5.9% | ||
| Q1 24 | 0.6% | 4.8% |
| Q4 25 | 1.10× | 6.08× | ||
| Q3 25 | 0.08× | 2.02× | ||
| Q2 25 | 1.75× | 0.92× | ||
| Q1 25 | 1.10× | 0.48× | ||
| Q4 24 | 1.60× | 15.23× | ||
| Q3 24 | 1.57× | 2.63× | ||
| Q2 24 | 2.46× | 59.35× | ||
| Q1 24 | 0.90× | -6.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
LCNB
Segment breakdown not available.
